Occhieppo, V. B., Basmadjian, O. M., Marchese, N. A., Jaime, A., Pérez, M. F., Baiardi, G. C., & Bregonzio, C. (2022). Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor.
Cita Chicago Style (17a ed.)Occhieppo, Victoria Belén, Osvaldo Martín Basmadjian, Natalia Andrea Marchese, Andrea Jaime, Mariela Fernanda Pérez, Gustavo Carlos Baiardi, y Claudia Bregonzio. Schizophrenia-like Endurable Behavioral and Neuroadaptive Changes Induced by Ketamine Administration Involve Angiotensin II AT1 Receptor. 2022.
Cita MLA (8a ed.)Occhieppo, Victoria Belén, et al. Schizophrenia-like Endurable Behavioral and Neuroadaptive Changes Induced by Ketamine Administration Involve Angiotensin II AT1 Receptor. 2022.